BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23515145)

  • 1. Genes associated with prostate cancer are differentially expressed in African American and European American men.
    Powell IJ; Dyson G; Land S; Ruterbusch J; Bock CH; Lenk S; Herawi M; Everson R; Giroux CN; Schwartz AG; Bollig-Fischer A
    Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):891-7. PubMed ID: 23515145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commercial Gene Expression Tests for Prostate Cancer Prognosis Provide Paradoxical Estimates of Race-Specific Risk.
    Creed JH; Berglund AE; Rounbehler RJ; Awasthi S; Cleveland JL; Park JY; Yamoah K; Gerke TA
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):246-253. PubMed ID: 31757784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences.
    Rayford W; Beksac AT; Alger J; Alshalalfa M; Ahmed M; Khan I; Falagario UG; Liu Y; Davicioni E; Spratt DE; Schaeffer EM; Feng FY; Mahal B; Nguyen PL; Den RB; Greenberger MD; Bradley R; Watson JM; Beamer M; Stamatakis L; Carmen DJ; Awasthi S; Hwang J; Weil R; Merisaari H; Mohamed N; Deane LA; Chakravarty D; Yadav KK; Yamoah K; Nair SS; Tewari AK
    Commun Biol; 2021 Jun; 4(1):670. PubMed ID: 34083737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer.
    Awasthi S; Berglund A; Abraham-Miranda J; Rounbehler RJ; Kensler K; Serna A; Vidal A; You S; Freeman MR; Davicioni E; Liu Y; Karnes RJ; Klein EA; Den RB; Trock BJ; Campbell JD; Einstein DJ; Gupta R; Balk S; Lal P; Park JY; Cleveland JL; Rebbeck TR; Freedland SJ; Yamoah K
    Clin Cancer Res; 2021 Jan; 27(1):320-329. PubMed ID: 33037017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous IL-6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild-type, African American PCa cells.
    Teslow EA; Bao B; Dyson G; Legendre C; Mitrea C; Sakr W; Carpten JD; Powell I; Bollig-Fischer A
    Mol Oncol; 2018 Jun; 12(7):1138-1152. PubMed ID: 29741809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Race-associated expression of MHC class I polypeptide-related sequence A (MICA) in prostate cancer.
    Sakiyama MJ; Espinoza I; Reddy A; de Carlo F; Kumar A; Levenson AS; Bae S; Zhou X; Claudio PP; Lewin J; Manucha V; Pound CR; Vijayakumar S; Gomez CR
    Exp Mol Pathol; 2019 Jun; 108():173-182. PubMed ID: 31004600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minireview: the molecular and genomic basis for prostate cancer health disparities.
    Powell IJ; Bollig-Fischer A
    Mol Endocrinol; 2013 Jun; 27(6):879-91. PubMed ID: 23608645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing prostate cancer racial disparity: evidence for aggressive early prostate cancer PSA testing of African American men.
    Powell IJ; Vigneau FD; Bock CH; Ruterbusch J; Heilbrun LK
    Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1505-11. PubMed ID: 24802741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should African-American men be tested for prostate carcinoma at an earlier age than white men?
    Powell IJ; Banerjee M; Sakr W; Grignon D; Wood DP; Novallo M; Pontes E
    Cancer; 1999 Jan; 85(2):472-7. PubMed ID: 10023717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate tumors of native men from West Africa show biologically distinct pathways-A comparative genomic study.
    Yamoah K; Asamoah FA; Abrahams AOD; Awasthi S; Mensah JE; Dhillon J; Mahal BA; Gueye SM; Jalloh M; Farahani SJ; Lal P; Rebbeck TR; Yarney J
    Prostate; 2021 Dec; 81(16):1402-1410. PubMed ID: 34529278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease.
    Powell IJ; Banerjee M; Novallo M; Sakr W; Grignon D; Wood DP; Pontes JE
    Urology; 2000 Feb; 55(2):246-51. PubMed ID: 10688088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-inflammatory cytokines and chemokines initiate multiple prostate cancer biologic pathways of cellular proliferation, heterogeneity and metastasis in a racially diverse population and underlie the genetic/biologic mechanism of racial disparity: Update.
    Powell IJ; Chinni SR; Reddy SS; Zaslavsky A; Gavande N
    Urol Oncol; 2021 Jan; 39(1):34-40. PubMed ID: 32900629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial differences in circulating mitochondria-derived peptides may contribute to prostate cancer health disparities.
    Ramirez-Torres A; Reagan AL; Howard LE; Wiggins E; Vidal AC; Wan J; Miller B; Freedland SJ; Cohen P
    Prostate; 2022 Sep; 82(13):1248-1257. PubMed ID: 35789022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology, pathology, and genetics of prostate cancer among African Americans compared with other ethnicities.
    Williams H; Powell IJ
    Methods Mol Biol; 2009; 472():439-53. PubMed ID: 19107447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated gene expression predicts tumor aggressiveness in African-American prostate cancer patients.
    Ali HEA; Lung PY; Sholl AB; Gad SA; Bustamante JJ; Ali HI; Rhim JS; Deep G; Zhang J; Abd Elmageed ZY
    Sci Rep; 2018 Nov; 8(1):16335. PubMed ID: 30397274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. African-American men and prostate cancer-specific mortality: a competing risk analysis of a large institutional cohort, 1989-2015.
    Williams VL; Awasthi S; Fink AK; Pow-Sang JM; Park JY; Gerke T; Yamoah K
    Cancer Med; 2018 May; 7(5):2160-2171. PubMed ID: 29601662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TMPRSS2-ERG fusion impacts anterior tumor location in men with prostate cancer.
    Yamoah K; Lal P; Awasthi S; Naghavi AO; Rounbehler RJ; Gerke T; Berglund AE; Pow-Sang JM; Schaeffer EM; Dhillon J; Park JY; Rebbeck TR
    Prostate; 2021 Feb; 81(2):109-117. PubMed ID: 33141952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline Mutations in African American Men With Prostate Cancer: Incidence, Implications and Diagnostic Disparities.
    Bree KK; Hensley PJ; Pettaway CA
    Urology; 2022 May; 163():148-155. PubMed ID: 34453957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for molecular differences in prostate cancer between African American and Caucasian men.
    Khani F; Mosquera JM; Park K; Blattner M; O'Reilly C; MacDonald TY; Chen Z; Srivastava A; Tewari AK; Barbieri CE; Rubin MA; Robinson BD
    Clin Cancer Res; 2014 Sep; 20(18):4925-34. PubMed ID: 25056375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
    Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
    JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.